Moreover, CCL2 has been reported as one of the targets of TTP, and when TTP is absent, CCL2 remains high throughout the body including blood, supporting the differentiation of MPs into M-MDSCs after mobilization (44–46). This evidence concerns the gene CCL2 and thrombotic thrombocytopenic purpura.